MDPI and ACS Style
Hu, W.; Zhang, L.; Ferri-Borgogno, S.; Kwan, S.-Y.; Lewis, K.E.; Cun, H.T.; Yeung, T.-L.; Soliman, P.T.; Tarapore, R.S.; Allen, J.E.;
et al. Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436. Cancers 2021, 13, 623.
https://doi.org/10.3390/cancers13040623
AMA Style
Hu W, Zhang L, Ferri-Borgogno S, Kwan S-Y, Lewis KE, Cun HT, Yeung T-L, Soliman PT, Tarapore RS, Allen JE,
et al. Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436. Cancers. 2021; 13(4):623.
https://doi.org/10.3390/cancers13040623
Chicago/Turabian Style
Hu, Wen, Li Zhang, Sammy Ferri-Borgogno, Suet-Ying Kwan, Kelsey E. Lewis, Han T. Cun, Tsz-Lun Yeung, Pamela T. Soliman, Rohinton S. Tarapore, Joshua E. Allen,
and et al. 2021. "Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436" Cancers 13, no. 4: 623.
https://doi.org/10.3390/cancers13040623